Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multicenter Clinical Study of Blood Microbial Metagenomic Next-Generation Sequencing (mNGS) for the Diagnosis of Invasive Pulmonary Fungal Disease in Patients With Hematologic Diseases

NCT07511595 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT07511595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07511595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multicenter Clinical Study of Blood Microbial Metagenomic Next-Generation Sequencing (mNGS) for the Diagnosis of Invasive Pulmonary Fungal Disease in Patients With Hematologic Diseases
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
July 31, 2029
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

invasive pulmonary fungal disease